 
This week, the California-based chip manufacturer reached a historic milestone, becoming the first company ever to exceed a market capitalisation of USD 5 trillion. Its share price rose by around 10% in October alone, driven by the growing importance of artificial intelligence and a series of new partnerships – including with OpenAI, Palantir, Oracle and the US Department of Energy. On Wednesday, the shares hit a new record high, closing at USD 204.04.
With its current market value, Nvidia now exceeds the economic output of Germany – Europe's largest economy generated a gross domestic product of EUR 4.3 trillion (around USD 4.8 trillion) in 2024.
US tech giants Microsoft and Apple follow in second and third place among the world's largest listed companies, each with a market capitalisation of around USD 4 trillion.
Despite their recent record-breaking run, analysts believe that Nvidia shares still have upside potential. According to Bloomberg, the twelve-month price target lies at USD 226.80. On 19 November, the US chip manufacturer will have to prove whether these lofty expectations can be substantiated by hard figures when it presents its third-quarter results.
For investors who want to benefit from the yield potential in Nvidia without investing directly in the shares, a reverse convertible may be an interesting option. The USD product has a strike of 87% and offers a guaranteed coupon of 12.80% p.a.
Reverse Convertibles on Nvidia
qCHF
11.00% p.a. RC on Nvidia
Strike: 90%
Valor: 149 282 134
USD
12.80% p.a. RC on Nvidia
Strike: 87%
Valor: 149 282 547
Indicative terms
Disclaimer
This communication is for marketing purposes. It is neither an offer nor an invitation to submit an offer, to purchase or to subscribe to securities and does not constitute investment advice. You should consult your advisors before making an investment decision. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, financial condition, development or performance of the issuer to be materially different from any future results, financial condition, development or performance expressed or implied by such statements. The present document has not been drawn up by the research department as defined in the rules of the “Directives on the Independence of Financial Research” published by the Swiss Bankers Association, hence these rules do not apply to this document. If securities are mentioned in the communication, the base prospectus, the final terms and any key information document may be obtained free of charge from Zürcher Kantonalbank, Bahnhofstrasse 9, 8001 Zurich, VRIS, and from www.zkb.ch/finanzinformationen.
© 2025 Zürcher Kantonalbank. All rights reserved.
| ZKB Barrier Reverse Convertible on worst of Moderna Inc/BioNTech SE 139434101 / CH1394341015 | 
| ZKB Callable Barrier Reverse Convertible on worst of Sonova Holding AG/Alcon AG/Straumann Holding AG... 140251442 / CH1402514421 | 
| ZKB Reverse Convertible auf Moderna Inc 144653131 / CH1446531316 | 
| ZKB Barrier Reverse Convertible on worst of Novartis AG/Roche Holding AG/Alcon AG 139433744 / CH1394337443 | 
| ZKB Tracker-Zertifikat auf Aktienbasket Wasserstofftechnologie 56679191 / CH0566791916 | 
